Femme et Homme
- | Pays :
- Austria
- | Organes : -
- | Spécialités : -
Extrait
Inhibition of RAS delays onset of diabetes in clinical studies. Preliminary evidence suggests that telmisartan may have unique metabolic properties compared to other ARB due to activation of PPARγ. This should be tested in comparison with an ARB that is metabolically neutral in already published studies. H0: Telmisartan is not different from Losartan with respect to metabolic and vascular effects. H1: Telmisartan is different from Losartan with respect to metabolic and vascular effects.
Critère d'inclusion
- Hypertension ,impaired glucose tolerance